Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules.
Cohen
Cyril J
CJ
Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Denkberg
Galit
G
Segal
Dina
D
Reiter
Yoram
Y
D017951:Antigen Presentation; D005818:Genetic Engineering / Q000379:methods*; D015395:Histocompatibility Antigens Class I / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D007167:Immunotherapy / Q000379:methods*; D000922:Immunotoxins / Q000009:adverse effects / Q000302:isolation & purification* / Q000627:therapeutic use*; D016296:Mutagenesis; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D010446:Peptide Fragments / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use*
D015395:Histocompatibility Antigens Class I; D007135:Immunoglobulin Variable Region; D000922:Immunotoxins; D010446:Peptide Fragments; D011994:Recombinant Proteins